| Literature DB >> 32393181 |
Xueying Luo1, Feng Li2, Haofei Hu2, Baoer Liu3, Sujing Zheng4, Liping Yang3, Rui Gao2, Ya Li5, Rao Xi6, Jinsong He7.
Abstract
BACKGROUND: Evidence regarding the relationship between anemia and perioperative prognosis is controversial. The study was conducted to highlight the specific relationship between anemia and perioperative mortality in non-cardiac surgery patients over 18 years of age.Entities:
Keywords: ICU admission; anemia; non-cardiac surgery; perioperative prognosis; postoperative 30day mortality; postoperative transfusion
Mesh:
Year: 2020 PMID: 32393181 PMCID: PMC7212669 DOI: 10.1186/s12871-020-01024-8
Source DB: PubMed Journal: BMC Anesthesiol ISSN: 1471-2253 Impact factor: 2.217
Baseline characteristics of participants
| FULL COHORT | Propensity Score–Matched Cohort | |||||
|---|---|---|---|---|---|---|
| ANEMIA | NONE OR MILD | MODERATE OR SEVERE | SD | NONE OR MILD | MODERATE OR SEVERE | SD |
| N | 75163 | 10826 | 8857 | 8857 | ||
| AGE (years) | 52.456 ± 16.456 | 58.142 ± 17.295 | 33.7% | 60.41 ± 15.94 | 59.23 ± 16.49 | 7.0% |
| sex | 33.2% | 9.0% | ||||
| Male | 35907 (47.772%) | 3435 (31.729%) | 2672 (30.17%) | 3061 (34.56%) | ||
| Female | 39256 (52.228%) | 7391 (68.271%) | 6185 (69.83%) | 5796 (65.44%) | ||
| RACE | 14.3% | 10.0% | ||||
| Chinese | 54347 (72.309%) | 7448 (68.797%) | 6267 (70.76%) | 6247 (70.53%) | ||
| Indian | 6570 (8.741%) | 976 (9.015%) | 666 (7.52%) | 774 (8.74%) | ||
| Malay | 7014 (9.332%) | 1489 (13.754%) | 1002 (11.31%) | 1132 (12.78%) | ||
| Others | 7228 (9.617%) | 913 (8.433%) | 922 (10.41%) | 704 (7.95%) | ||
| PREOP-EGFR | 69.304-104.537 | 27.641-106.590 | 26.5% | 42.39-98.44 | 28.36-107.44 | 3.0% |
| RDW N (%) | 99.4% | 56.0% | ||||
| RDW≤15.7 | 69383 (92.310%) | 6013 (55.542%) | 7373 (83.24%) | 5263 (59.42%) | ||
| RDW>15.7 | 3765 (5.009%) | 4659 (43.035%) | 1426 (16.10%) | 3569 (40.30%) | ||
| NA | 2015 (2.681%) | 154 (1.423%) | 58 (0.65%) | 25 (0.28%) | ||
| Preop-transfusion with in 30days n(%) | 41.9% | 3.0% | ||||
| 0 units | 74439 (99.037%) | 9690 (89.507%) | 8247 (93.11%) | 8208 (92.67%) | ||
| 1 unit | 410 (0.545%) | 597 (5.515%) | 340 (3.84%) | 339 (3.83%) | ||
| 2 or more units | 314 (0.418%) | 539 (4.979%) | 270 (3.05%) | 310 (3.50%) | ||
| Intraop-transfusion | 68.1% | 2.0% | ||||
| 0 units | 72917 (97.012%) | 8063 (74.478%) | 7105 (80.22%) | 7170 (80.95%) | ||
| 1 unit | 2246 (2.988%) | 2763 (25.522%) | 1752 (19.78%) | 1687 (19.05%) | ||
| CVA CATEGORY | 13.1% | 2.0% | ||||
| NO | 51068 (67.943%) | 7133 (65.888%) | 5819 (65.70%) | 5864 (66.21%) | ||
| YES | 1142 (1.519%) | 386 (3.565%) | 302 (3.41%) | 325 (3.67%) | ||
| NA | 22953 (30.538%) | 3307 (30.547%) | 2736 (30.89%) | 2668 (30.12%) | ||
| CHF CATEGORY | 17.2% | 4.0% | ||||
| NO | 53543 (71.236%) | 7415 (68.493%) | 6114 (69.03%) | 6132 (69.23%) | ||
| YES | 475 (0.632%) | 308 (2.845%) | 191 (2.16%) | 247 (2.79%) | ||
| NA | 21145 (28.132%) | 3103 (28.662%) | 2552 (28.81%) | 2478 (27.98%) | ||
| IHD CATEGORY | 22.9% | 4.0% | ||||
| NO | 48887 (65.041%) | 6416 (59.265%) | 5248 (59.25%) | 5252 (59.30%) | ||
| YES | 3128 (4.162%) | 1068 (9.865%) | 816 (9.21%) | 909 (10.26%) | ||
| NA | 23148 (30.797%) | 3342 (30.870%) | 2793 (31.53%) | 2696 (30.44%) | ||
| DM CATEGORY | 25.7% | 13.0% | ||||
| NO | 52257 (69.525%) | 6909 (63.819%) | 5868 (66.25%) | 5711 (64.48%) | ||
| YES | 1262 (1.679%) | 723 (6.678%) | 342 (3.86%) | 607 (6.85%) | ||
| NA | 21644 (28.796%) | 3194 (29.503%) | 2647 (29.89%) | 2539 (28.67%) | ||
| Anesthesia type n(%) | 17.7% | 5.0% | ||||
| ga | 63448 (84.414%) | 8389 (77.489%) | 6805 (76.83%) | 6989 (78.91%) | ||
| ra | 11715 (15.586%) | 2437 (22.511%) | 2052 (23.17%) | 1868 (21.09%) | ||
| Priority of surgery n(%) | 33.2% | 8.0% | ||||
| Elective | 60799 (80.890%) | 7197 (66.479%) | 5809 (65.59%) | 6160 (69.55%) | ||
| Emergency | 14364 (19.110%) | 3629 (33.521%) | 3048 (34.41%) | 2697 (30.45%) | ||
| Surgical risk | 26.7% | 7.0% | ||||
| Low | 39779 (52.924%) | 4531 (41.853%) | 3599 (40.63%) | 3880 (43.81%) | ||
| Moderate | 32691 (43.493%) | 5417 (50.037%) | 4612 (52.07%) | 4314 (48.71%) | ||
| High | 2693 (3.583%) | 878 (8.110%) | 646 (7.29%) | 663 (7.49%) | ||
| RCRI CATEGORY | 52.7% | 18.0% | ||||
| I | 41157 (54.757%) | 3769 (34.814%) | 3484 (39.34%) | 3138 (35.43%) | ||
| II | 9884 (13.150%) | 2516 (23.240%) | 1766 (19.94%) | 2066 (23.33%) | ||
| III | 1559 (2.074%) | 869 (8.027%) | 476 (5.37%) | 728 (8.22%) | ||
| IV | 473 (0.629%) | 407 (3.759%) | 224 (2.53%) | 336 (3.79%) | ||
| NA | 22090 (29.389%) | 3265 (30.159%) | 2907 (32.82%) | 2589 (29.23%) | ||
| ASA CATEGORY | 72.3% | 35.0% | ||||
| 1 | 18716 (24.901%) | 1109 (10.244%) | 1117 (12.61%) | 816 (9.21%) | ||
| 2 | 43132 (57.385%) | 4592 (42.416%) | 4447 (50.21%) | 3839 (43.34%) | ||
| 3 | 9813 (13.056%) | 4453 (41.132%) | 2379 (26.86%) | 3738 (42.20%) | ||
| NA | 3502 (4.659%) | 672 (6.207%) | 914 (10.32%) | 464 (5.24%) | ||
| Postop- transfusion | 40.7% | 28.0% | ||||
| 0 units | 75081 (99.891%) | 9966 (92.056%) | 8787 (99.21%) | 8352 (94.30%) | ||
| ≥1 unit | 82 (0.109%) | 860 (7.944%) | 70 (0.79%) | 505 (5.70%) | ||
| ICUADMGT24H | 19.1% | 00.0% | ||||
| No | 74366 (98.940%) | 10386 (95.936%) | 8542 (96.44%) | 8542 (96.44%) | ||
| Yes | 797 (1.060%) | 440 (4.064%) | 315 (3.56%) | 315 (3.56%) | ||
| THIRTY-DAY MORTALITY N(%) | 21.4% | 09.0% | ||||
| No | 74955 (99.723%) | 10505 (97.035%) | 8749 (98.78%) | 8638 (97.53%) | ||
| Yes | 208 (0.277%) | 321 (2.965%) | 108 (1.22%) | 219 (2.47%) | ||
Noted: SD was calculated by Kruskal-Wallis H test
Abbreviations: GA general anesthesia, RA regional anesthesia, PREOP-eGFR preoperative estimated glomerular filtration rate (mL/min/1.73m2), RDW red cell distribution, NA not available, CVA cerebrovascular accidents, IHD ischemic heart disease, CHF congestive heart failure, DM diabetes mellitus requiring insulin therapy; creatinine>2.0mg/dl, Preop preoperative, Intraop intraoperative, Postop postoperative, RCRI Revised Cardiac Risk Index, ASA American Society of Anesthesiologists, ICU Intensive Care Unit, ICUADMGT24H admission to ICU for >24 hours
Fig. 1Study Population
The results of univariate and multivariate analyses before propensity score matching
| ANEMIA | model i | ModEL iI | ModEL iIi |
|---|---|---|---|
| Postop- transfusion | |||
| None or mild | Ref | Ref | Ref |
| Moderate or severe | 79.01 (62.936, 99.194) <0.001 | 76.924 (61.075, 96.885) <0.001 | 7.187 (5.557, 9.296) <0.001 |
| ICUADMGT24H | |||
| None or mild | Ref | Ref | Ref |
| Moderate or severe | 3.953 (3.512, 4.449) <0.001 | 3.560 (3.146, 4.028) <0.001 | 0.848 (0.714, 1.008) 0.061 |
| THIRTY-DAY MORTALITY | |||
| None or mild | Ref | Ref | Ref |
| Moderate or severe | 11.011 (9.238, 13.126) <0.001 | 8.395 (6.989, 10.084) <0.001 | 1.917 (1.531, 2.400) <0.001 |
The results were expressed as odds ratio (95%confidence interval) P-value
MODEL I (Non-adjusted model): we did not adjust any covariate
MODEL II (Minimally-adjusted model): we only adjusted age, gender and race
MODEL III (Fully-adjusted model): we adjusted age, sex, race, preoperative eGFR, presence of CVA,DM, IHD, CHF, RDW, priority of surgery, anesthesia type, surgical risk, preoperative blood transfusion with in 30days, intraoperative blood transfusion data, the RCRI score,the ASA status.
The results of univariate and multivariate analyses in propensity score matched cohort
| ANEMIA | model i* | ModEL iI* | ModEL iIi* |
|---|---|---|---|
| Postop- transfusion | |||
| None or mild | Ref | Ref | Ref |
| Moderate or severe | 8.566 (6.571, 11.17) <0.001 | 7.456 (5.397, 10.30) <0.001 | 5.608 (4.026, 7.811) <0.001 |
| ICUADMGT24H | |||
| None or mild | Ref | Ref | Ref |
| Moderate or severe | 0.923 (0.784, 1.087) 0.337 | 0.964 (0.759, 1.224) 0.763 | 0.810 (0.628, 1.044) 0.104 |
| THIRTY-DAY MORTALITY | |||
| None or mild | Ref | Ref | Ref |
| Moderate or severe | 1.936 (1.530, 2.449) <0.001 | 1.996 (1.413, 2.819) <0.001 | 1.510 (1.049, 2.174) 0.027 |
The results were expressed as odds ratio (95%confidence interval) P-value
MODEL I* ( The propensity score-based patient-matching model): we adjusted for propensity score
MODEL II* (The propensity score-based IPW model):we did not adjust any covariates with the propensity score-based IPW
MODEL III*(The doubly robust estimation model): we adjusted for DM, RDW,the RCRI score, the ASA status, with the propensity score-based IPW